AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Eli Lilly and Comp. (LLY) stock forecast for 2026
The forecast has been updated: November 17, 2022 8:38
Eli Lilly and Comp. stock price online today
Analyst Target Price
379Dividend Date
09.12.2022Ex Dividend Date
14.11.2022Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Eli Lilly and Comp. stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? Eli Lilly and Comp. stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $379 target price for Eli Lilly and Comp. stock stock.
Today 200 Day Moving Average is the support level (303.8 $).
50 Day Moving Average is the support level (332.33 $).
LLY Forecast for 2026
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 167.08 | 156.87 | 178.37 | 12.06 % |
| Feb | 161.87 | 145.24 | 176.81 | 17.85 % |
| Mar | 163.76 | 156.10 | 177.39 | 12.00 % |
| Apr | 143.96 | 139.47 | 154.82 | 9.91 % |
| May | 151.82 | 145.11 | 161.49 | 10.14 % |
| Jun | 152.61 | 142.69 | 157.37 | 9.33 % |
| Jul | 144.08 | 129.85 | 154.20 | 15.79 % |
| Aug | 156.26 | 149.76 | 170.68 | 12.26 % |
| Sep | 151.18 | 142.53 | 163.76 | 12.96 % |
| Oct | 164.15 | 150.71 | 169.06 | 10.85 % |
| Nov | 175.03 | 169.80 | 181.86 | 6.63 % |
| Dec | 192.55 | 186.29 | 207.57 | 10.25 % |
The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Eli Lilly and Comp. stock.
Eli Lilly and Comp. overview
Eli Lilly and Comp. Address
LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, USMarket Capitalization
332 514 800 000 $EBITDA
10 380 400 000PE Ratio
44.87PEG Ratio
2.125Dividend Per Share
3.79Dividend Yield
0.0111EPS
6.65Quarterly Earnings Growth YOY
0.32Quarterly Revenue Growth YOY
0.025Trailing PE
52.62Forward PE
38.02EV To Revenue
12.02EV To EBITDA
41.4952 Week High
368.8252 Week Low
229.5750 Day Moving Average
332.33200 Day Moving Average
303.8Shares Outstanding
950178000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Eli Lilly and Comp. stock forecast for this year
Eli Lilly and Comp. stock forecast for Jan 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 167.08. Negative monthly dynamics of the instrument is expected with 12.055% volatility is expected.
Pessimistic forecast: 156.87
Optimistic: 178.37
Eli Lilly and Comp. stock forecast for Feb 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 161.87. Negative monthly dynamics of the instrument is expected with 17.852% volatility is expected.
Pessimistic forecast: 145.24
Optimistic: 176.81
Eli Lilly and Comp. stock forecast for Mar 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 163.76. Positive monthly dynamics of the instrument is expected with 12.002% volatility is expected.
Pessimistic forecast: 156.10
Optimistic: 177.39
Eli Lilly and Comp. stock forecast for Apr 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 143.96. Negative monthly dynamics of the instrument is expected with 9.913% volatility is expected.
Pessimistic forecast: 139.47
Optimistic: 154.82
Eli Lilly and Comp. stock forecast for May 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 151.82. Positive monthly dynamics of the instrument is expected with 10.143% volatility is expected.
Pessimistic forecast: 145.11
Optimistic: 161.49
Eli Lilly and Comp. stock forecast for Jun 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 152.61. Positive monthly dynamics of the instrument is expected with 9.329% volatility is expected.
Pessimistic forecast: 142.69
Optimistic: 157.37
Eli Lilly and Comp. stock forecast for Jul 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 144.08. Negative monthly dynamics of the instrument is expected with 15.791% volatility is expected.
Pessimistic forecast: 129.85
Optimistic: 154.20
Eli Lilly and Comp. stock forecast for Aug 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 156.26. Positive monthly dynamics of the instrument is expected with 12.259% volatility is expected.
Pessimistic forecast: 149.76
Optimistic: 170.68
Eli Lilly and Comp. stock forecast for Sep 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 151.18. Negative monthly dynamics of the instrument is expected with 12.961% volatility is expected.
Pessimistic forecast: 142.53
Optimistic: 163.76
Eli Lilly and Comp. stock forecast for Oct 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 164.15. Positive monthly dynamics of the instrument is expected with 10.855% volatility is expected.
Pessimistic forecast: 150.71
Optimistic: 169.06
Eli Lilly and Comp. stock forecast for Nov 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 175.03. Positive monthly dynamics of the instrument is expected with 6.632% volatility is expected.
Pessimistic forecast: 169.80
Optimistic: 181.86
Eli Lilly and Comp. stock forecast for Dec 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 192.55. Positive monthly dynamics of the instrument is expected with 10.250% volatility is expected.
Pessimistic forecast: 186.29
Optimistic: 207.57
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
 Abbott Laboratories
|
ABT | 98.07 (04.11.2022) | 1.68 % |
 AbbVie Inc.
|
ABBV | 145.28 (04.11.2022) | 0.60 % |
 Aeterna Zentaris Inc.
|
AEZS | 4.01 (04.11.2022) | 2.82 % |
 Allakos Inc.
|
ALLK | 5.99 (04.11.2022) | 5.83 % |
 Allogene Therapeutics, Inc.
|
ALLO | 9.34 (04.11.2022) | -1.89 % |
 Amgen Inc.
|
AMGN | 269.04 (04.11.2022) | 1.19 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 4.75 (04.11.2022) | 2.15 % |
 Aurora Cannabis Inc.
|
ACB | 1.31 (04.11.2022) | -5.07 % |
 Becton Dickinson and Company
|
BDX | 220.84 (04.11.2022) | -0.07 % |
 Biogen Inc.
|
BIIB | 281.82 (04.11.2022) | 0.56 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 15.47 (04.11.2022) | 4.60 % |
 BioNTech SE
|
BNTX | 154.31 (04.11.2022) | 6.24 % |
 bluebird bio, Inc.
|
BLUE | 6.13 (04.11.2022) | -2.23 % |
 Boston Scientific Corp.
|
BSX | 41.59 (04.11.2022) | 0.14 % |
 Bristol-Myers Squibb Company
|
BMY | 78.78 (04.11.2022) | 0.38 % |
 Canopy Growth Corp.
|
CGC | 3.29 (04.11.2022) | -4.64 % |
 Castle Biosciences, Inc.
|
CSTL | 21.94 (04.11.2022) | -9.60 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
|
Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
 Emergent BioSolutions Inc.
|
EBS | 19.96 (04.11.2022) | 2.20 % |
 Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
 G1 Therapeutics, Inc.
|
GTHX | 8.32 (04.11.2022) | 4.92 % |
 Gilead Sciences, Inc.
|
GILD | 80.34 (04.11.2022) | 1.11 % |
 GlaxoSmithKline plc
|
GSK | 32.99 (04.11.2022) | 0.46 % |
 GoodRx Holdings, Inc.
|
GDRX | 5.06 (04.11.2022) | 3.27 % |
 GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 77.3 (04.11.2022) | 0.52 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 2.11 (04.11.2022) | -1.40 % |
 Johnson & Johnson
|
JNJ | 171.48 (04.11.2022) | 0.45 % |
 Medtronic plc.
|
MDT | 84.65 (04.11.2022) | 0.75 % |
 Merck & Co., Inc.
|
MRK | 99.2 (04.11.2022) | 0.46 % |
 Moderna, Inc.
|
MRNA | 158.41 (04.11.2022) | 7.40 % |
 Novartis AG
|
NVS | 81.72 (04.11.2022) | 1.67 % |
 Novavax, Inc.
|
NVAX | 19.4 (04.11.2022) | -3.82 % |
 ObsEva SA
|
OBSV | 0.1688 (04.11.2022) | 0.60 % |
 OrganiGram Holdings Inc.
|
OGI | 0.9738 (04.11.2022) | 0.11 % |
 Pfizer Inc.
|
PFE | 47.22 (04.11.2022) | 1.40 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 740.21 (04.11.2022) | 0.21 % |
 Sanofi
|
SNY | 43.62 (04.11.2022) | 1.82 % |
 Schrodinger, Inc.
|
SDGR | 20.92 (04.11.2022) | -15.17 % |
 Senseonics Holdings, Inc.
|
SENS | 1.18 (04.11.2022) | -0.84 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 1.46 (04.11.2022) | -1.35 % |
 Stryker Corp.
|
SYK | 210.98 (04.11.2022) | 2.66 % |
 Sundial Growers Inc.
|
SNDL | 2.32 (04.11.2022) | -2.52 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.47 (04.11.2022) | -1.63 % |
 Thermo Fisher Scientific Inc.
|
TMO | 495.55 (04.11.2022) | 1.77 % |
 Tilray, Inc.
|
TLRY | 3.81 (04.11.2022) | -0.26 % |
 UnitedHealth Group, Inc.
|
UNH | 538.17 (04.11.2022) | -1.00 % |
 Veeva Systems Inc.
|
VEEV | 166.81 (04.11.2022) | -0.20 % |
|
Zomedica Corp.
|
ZOM | 0.2245 (04.11.2022) | -2.01 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 0.7051 (04.11.2022) | -2.07 % |
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.